Z-(9RS,10RS)-9,10-dihydroxy-6-phenyl-2-cyclodecen-1-one | 471910-76-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Z-(9RS,10RS)-9,10-dihydroxy-6-phenyl-2-cyclodecen-1-one
• 英文别名: (2Z)-9,10-dihydroxy-6-phenylcyclodec-2-en-1-one
• CAS: 471910-76-6
• 化学式: C₁₆H₂₀O₃
• 分子量: 260.333
• InChiKey: CAQQNQUFMGBDKG-UITAMQMPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  19
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Cyclooctanone derivatives and cyclodecanone derivative, and use thereof
  申请人：——

  公开号：US20040082805A1

  公开（公告）日：2004-04-29

  The present invention provides a compound which has cytokine production inhibitory activity and is useful for the treatment of diseases which is associated with cytokine. The compound is represented by the following general formula (I) [wherein A represents a cyclic group which may be substituted; the partial structure -D E- represents a group represented by —CH 2 CH 2 — or —CH═CH—; W represents a group represented by —CH 2 —, —CH 2 CH 2 —, —CH═CH— or —CH═; the partial structure >X Y—represents a group represented by >CH—(CH 2 ) n —, >C═CH—, >CH—CH 2 —CH(OH)—, >CH—CH 2 —C(═O)—, >CH—O— or >CH—O—CO—, provided that when W is —CH═, then X Y— represents C—(CH 2 ) p —; Z represents a divalent aliphatic hydrocarbon group; R 1 and R 2 , which may be the same or different, each represents a hydrogen atom, or a hydroxyl, alkoxy or alkoxyalkoxy group; m is an integer of 0 or 1].

  本发明提供了一种具有细胞因子生产抑制活性的化合物，可用于治疗与细胞因子相关的疾病。该化合物由以下通式(I)表示：[其中，A表示可以被取代的环状基团；部分结构-DE-表示由— —或—CH═CH—表示的基团；W表示由—CH2—、— —、—CH═CH—或—CH═—表示的基团；部分结构>XY-表示由>CH—( )n—、>C═CH—、>CH— —CH(OH)—、>CH— —C(═O)—、>CH—O—或>CH—O—CO—表示的基团，但当W为—CH═时，XY—表示C—( )p—；Z表示二价的脂肪族碳氢基团；R1和R2，可以相同也可以不同，每个表示氢原子或羟基、烷氧基或烷氧基烷基；m是0或1的整数。]
• PYRROLIDINE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
  申请人：Eisai Co., Ltd.

  公开号：EP1375479A1

  公开（公告）日：2004-01-02

  The present invention provides a compound which has cytokine production inhibitory activity and is useful for the treatment of diseases which is associated with cytokine. The compound is represented by the following general formula (I) [wherein A represents a cyclic group which may be substituted; the partial structure -D---E- represents a group represented by -CH2CH2- or -CH=CH-; W reprensents a group represented by -CH2-, - CHzCH2-, -CH=CH- or -CH=; the partial structure >X---Y- represents a group represented by >CH-(CH2)n-, >C=CH-, >CH-CH2-CH(OH)-, >CH-CH2-C (=O) -, >CH-O- or >CH-O-CO-, provided that when W is -CH=, then X---Y- represents C-(CH2)p-; Z represents a divalent aliphatic hydrocarbon group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a hydroxyl, alkoxy or alkoxyalkoxy group; m is an integer of 0 or 1] .

  本发明提供了一种化合物，它具有抑制细胞因子产生的活性，可用于治疗与细胞因子有关的疾病。该化合物由以下通式（I）表示[其中 A 代表可被取代的环状基团；部分结构-D--E-代表由- -或-CH=CH-代表的基团；W 代表由-CH2-、-CHz -、-CH=CH-或-CH=；部分结构 >X---Y- 代表由 >CH-( )n-、>C=CH-、>CH- -CH(OH)-、>CH- -C (=O) -、>CH-O- 或 >CH-O-CO- 所代表的基团，条件是当 W 为 -CH= 时，则 X---Y- 代表 C-( )p-；Z 代表二价脂肪族烃基； R1 和 R2 可以相同或不同，各自代表氢原子或羟基、烷氧基或烷氧烷氧基； m 是 0 或 1 的整数]。
• CYCLOOCTANONE DERIVATIVE AND CYCLODECANONE DERIVATIVE, AND USE THEREOF
  申请人：Eisai Co., Ltd.

  公开号：EP1375465A9

  公开（公告）日：2004-04-14

  The present invention provides a compound which has cytokine production inhibitory activity and is useful for the treatment of diseases which is associated with cytokine. The compound is represented by the following general formula (I) [wherein A represents a cyclic group which may be substituted; the partial structure -D---E- represents a group represented by -CH2CH2- or -CH=CH-; W reprensents a group represented by -CH2-, - CH2CH2-, -CH=CH- or -CH=; the partial structure >X---Y- represents a group represented by >CH-(CH2)n-, >C=CH-, >CH-CH2-CH(OH)-, >CH-CH2-C (=O) -, >CH-O- or >CH-O-CO-, provided that when W is -CH=, then X---Y- represents C-(CH2)p-; Z represents a divalent aliphatic hydrocarbon group; R1 and R2, which may be the same or different, each represents a hydrogen atom, or a hydroxyl, alkoxy or alkoxyalkoxy group; m is an integer of 0 or 1] .

  本发明提供了一种化合物，它具有抑制细胞因子产生的活性，可用于治疗与细胞因子有关的疾病。该化合物由以下通式（I）表示[其中 A 代表可被取代的环状基团；部分结构-D--E-代表由- -或-CH=CH-代表的基团；W 代表由-CH2-、- -、-CH=CH-或-CH=；部分结构 >X---Y- 代表由 >CH-( )n-、>C=CH-、>CH- -CH(OH)-、>CH- -C (=O) -、>CH-O- 或 >CH-O-CO- 所代表的基团，条件是当 W 为 -CH= 时，则 X---Y- 代表 C-( )p-；Z 代表二价脂肪族烃基； R1 和 R2 可以相同或不同，各自代表氢原子或羟基、烷氧基或烷氧烷氧基； m 是 0 或 1 的整数]。
• US6949585B2
  申请人：——

  公开号：US6949585B2

  公开（公告）日：2005-09-27